Camber Capital Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-4,000,000
| Closed | -$29.6M | – | 44 |
|
|
2016
Q2 | $29.6M | Sell |
4,000,000
-1,405,235
| -26% | -$10.4M | 1.43% | 26 |
|
|
2016
Q1 | $34.5M | Hold |
5,405,235
| – | – | 2.02% | 23 |
|
|
2015
Q4 | $33.8M | Sell |
5,405,235
-127,883
| -2% | -$799K | 2.18% | 20 |
|
|
2015
Q3 | $32.3M | Sell |
5,533,118
-216,882
| -4% | -$1.27M | 2.77% | 15 |
|
|
2015
Q2 | $47.6M | Sell |
5,750,000
-1,250,000
| -18% | -$10.3M | 3.24% | 14 |
|
|
2015
Q1 | $57.7M | Sell |
7,000,000
-500,000
| -7% | -$4.12M | 4.12% | 6 |
|
|
2014
Q4 | $51.5M | Buy |
7,500,000
+1,500,000
| +25% | +$10.3M | 3.43% | 8 |
|
|
2014
Q3 | $32.4M | Buy |
6,000,000
+1,000,000
| +20% | +$5.4M | 3.04% | 14 |
|
|
2014
Q2 | $31.9M | Buy |
5,000,000
+2,000,000
| +67% | +$12.7M | 2.09% | 18 |
|
|
2014
Q1 | $24.2M | Sell |
3,000,000
-2,250,000
| -43% | -$18.1M | 1.89% | 16 |
|
|
2013
Q4 | $35.8M | Buy |
+5,250,000
| New | +$35.8M | 3.16% | 14 |
|